Vote Now
Home | News | Events | Press | Contact  

About UseNewsletterMessage BoardsAction CenterAdvocateWalk to End Alzheimer’sShopDonate

Find your chapter:

search by state

In My Community

Weekly e-news

We will not share your information.

Drug study in Tri-Cities seeks participants
Text Size controlsNormal font sizeMedium font sizeLarge font size

Zain Research in Richland, WA, is seeking research participants. Zain is now conducting a 26-week, Phase 3 study for participants with Mild to Moderate Alzheimer’s disease currently or previously receiving an acetylcholinesterase (AChEl) inhibitor medication. If eligible, participants may receive compensation for time and travel, close medical monitoring, and an optional open label dosing for 6 additional months. For additional information, contact Zain Research at 509.420.5053.


Join or start a team today.

Find a Walk

Washington Alaska Texas Washington Oregon California Idaho Nevada Arizona Utah Montana Wyoming Colorado New Mexico Oklahoma Kansas Nebraska South Dakota North Dakota Minnesota Iowa Missouri Arkansas Louisiana Mississippi Illinois Wisconsin Michigan Indiana Kentucky Tennessee Alabama Florida Georgia South Carolina North Carolina Virginia West Virginia Ohio Maine Pennsylvania New York Vermont New Hampshire Massachusetts Rhode Island Connecticut New Jersey onClick= Delaware Maryland Hawaii Vermont New Hampshire Massachusetts Rhode Island Connecticut New Jersey Delaware Maryland Washington D.C.
Alzheimer's Association

Our vision is a world without Alzheimer's
Formed in 1980, the Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research.